Summary of all the Indicators
Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Lineage Cell Therapeutics, Inc.’s (BT3) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Lineage Cell Therapeutics, Inc. is a Sell.
Lineage Cell Therapeutics, Inc.’s (BT3) 20-Day exponential moving average is 0.93, while Lineage Cell Therapeutics, Inc.’s (BT3) share price is €0.92, making it a Sell.
Lineage Cell Therapeutics, Inc.’s (BT3) 50-Day exponential moving average is 0.97, while Lineage Cell Therapeutics, Inc.’s (BT3) share price is €0.92, making it a Sell.
Lineage Therap (BT3) Pivot Points
Classic
0.93
0.93
0.93
0.93
0.93
0.93
0.93
Fibonacci
0.93
0.93
0.93
0.93
0.93
0.93
0.93
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Lineage Therap (BT3) Moving Averages
MA5
0.92Sell
0.92Sell
MA10
0.93Sell
0.92Sell
MA20
0.92Sell
0.93Sell
MA50
0.98Sell
0.97Sell
MA100
1.05Sell
1.05Sell
MA200
1.23Sell
1.19Sell
Lineage Cell Therapeutics, Inc.’s (BT3) 10-Day exponential moving average is 0.92, while Lineage Cell Therapeutics, Inc.’s (BT3) share price is €0.92, making it a Sell.
Lineage Cell Therapeutics, Inc.’s (BT3) 100-Day exponential moving average is 1.05, while Lineage Cell Therapeutics, Inc.’s (BT3) share price is €0.92, making it a Sell.
Lineage Cell Therapeutics, Inc.’s (BT3) stock price is €0.92 and Lineage Cell Therapeutics, Inc.’s (BT3) 50-day simple moving average is 0.98, creating a Sell signal.
Lineage Cell Therapeutics, Inc.’s (BT3) stock price is €0.92 and Lineage Cell Therapeutics, Inc.’s (BT3) 100-day simple moving average is 1.05, creating a Sell signal.
Lineage Cell Therapeutics, Inc.’s (BT3) stock price is €0.92 and Lineage Cell Therapeutics, Inc.’s (BT3) 200-day simple moving average is 1.23, creating a Sell signal.
Lineage Therap (BT3) Technical Indicators
RSI (14)
46.03
Neutral
STOCH (9,6)
16.36
Buy
STOCHRSI (14)
41.77
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
12.87
Buy
Williams %R
-60.76
Buy
CCI (14)
-9.40
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
46.96
Neutral
ROC
2.68
Buy
Lineage Cell Therapeutics, Inc.’s (BT3) Relative Strength Index (RSI) is 46.03, creating a Neutral signal.
Lineage Cell Therapeutics, Inc.’s (BT3) Trend Strength Indicator (ADX) is 12.87, creating a Buy signal.
Lineage Cell Therapeutics, Inc.’s (BT3) Commodity Channel Index (CCI) is -9.40, creating a Neutral signal.
Lineage Cell Therapeutics, Inc.’s (BT3) Price Rate of Change (ROC) is 2.68, creating a Buy signal.
FAQ
Is BT3 a Buy, Hold, or Sell?
Based on BT3’s technical indicators, BT3 is a Sell.
What is BT3’s RSI (14)?
BT3’s RSI (14) is 46.03, which suggests BT3 is a Neutral.
What is BT3’s MACD?
BT3’s MACD is >-0.01, which suggests BT3 is a Sell.
What is BT3’s 5-day moving average?
BT3’s 5-day moving average is 0.92, which suggests BT3 is a Sell.
What is BT3’s 20-day moving average?
BT3 20-day moving average is 0.92, which suggests BT3 is a Sell.
What is BT3’s 50-day moving average?
BT3’s 50-day moving average is 0.98, which suggests BT3 is a Sell.
What is BT3’s 200-day moving average?
BT3’s 200-day moving average is 1.23, which suggests BT3 is a Sell.
What is BT3’s Williams % R (14)?
BT3’s Williams % R (14) is -60.76, which suggests BT3 is a Buy.
What is BT3’s CCI (14)?
BT3’s CCI (14) is -9.40, which suggests BT3 is a Neutral.
What is the share price of Lineage Cell Therapeutics, Inc.?
Lineage Therap's share price is N/A€.